| NSF Org: |
TI Translational Impacts |
| Recipient: |
|
| Initial Amendment Date: | February 9, 2021 |
| Latest Amendment Date: | February 9, 2021 |
| Award Number: | 2052219 |
| Award Instrument: | Standard Grant |
| Program Manager: |
Henry Ahn
hahn@nsf.gov (703)292-7069 TI Translational Impacts TIP Directorate for Technology, Innovation, and Partnerships |
| Start Date: | February 15, 2021 |
| End Date: | December 31, 2021 (Estimated) |
| Total Intended Award Amount: | $256,000.00 |
| Total Awarded Amount to Date: | $256,000.00 |
| Funds Obligated to Date: |
|
| History of Investigator: |
|
| Recipient Sponsored Research Office: |
5485 CONESTOGA CT STE 210 BOULDER CO US 80301-2757 (720)507-6699 |
| Sponsor Congressional District: |
|
| Primary Place of Performance: |
5485 Conestoga Ct, #210 Boulder CO US 80303-2714 |
| Primary Place of
Performance Congressional District: |
|
| Unique Entity Identifier (UEI): |
|
| Parent UEI: |
|
| NSF Program(s): | SBIR Phase I |
| Primary Program Source: |
|
| Program Reference Code(s): |
|
| Program Element Code(s): |
|
| Award Agency Code: | 4900 |
| Fund Agency Code: | 4900 |
| Assistance Listing Number(s): | 47.084 |
ABSTRACT
The objective of this Small Business Innovation Research (SBIR) Phase I project is to create a wearable sensor that monitors ovulation hormones to aid conception. The end product will make fertility tracking and treatment more convenient, accessible and affordable to the 7.5 million American couples currently struggling to grow their families. Patients undergoing infertility treatments typically have to visit a fertility clinic 3-8 times during a single ovulation cycle to assess circulating reproductive hormone levels in the blood. These frequent clinic visits create high costs and a burden, decreasing overall access to infertility care. This project will develop an affordable, accurate, at-home fertility-monitoring solution.
This Small Business Innovation Research (SBIR) Phase I project proposes research towards the development of a low-cost ovulation monitoring wearable to accurately track reproductive hormones during the menstrual cycle. The proposed low-cost, wearable device will capture hormone peaks in real time. This project will demonstrate that the proposed technology can continuously monitor reproductive hormones and that the data generated of equivalent quality and accuracy compared to standard blood draws. Furthermore, the proposed research will validate the device?s ability to function over multiple days.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
PROJECT OUTCOMES REPORT
Disclaimer
This Project Outcomes Report for the General Public is displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed in this Report are those of the PI and do not necessarily reflect the views of the National Science Foundation; NSF has not approved or endorsed its content.
This Small Business Innovation Research (SBIR) Phase I project demonstrated feasibility to create a wearable sensor that monitors ovulation hormones to aid conception. The end product will make fertility tracking and treatment more convenient, accessible and affordable to the 7.5 million Americans currently struggling to grow their families. Patients undergoing infertility treatments typically have to visit a fertility clinic 3-8 times during a single ovulation cycle to assess circulating reproductive hormone levels in the blood. These frequent clinic visits create high costs and a burden, decreasing overall access to infertility care.
This project has demonstrated that biosensors for reproductive hormones can provide the performance required for affordable, accurate, at-home fertility-monitoring solution. Specifically, the product will be a low-cost ovulation monitoring wearable to accurately track reproductive hormones during the menstrual cycle. The proposed low-cost, wearable device uses a pain-free minimally-invasive approach to couple hormones in the body to a tiny electrochemical sensor placed just above the skin surface. Under Phase I SBIR Research, the project demonstrated measurement time resolutions that are equivalent in quality and accuracy compared to standard blood draws. Furthermore, the Phase I SBIR research has shown feasibility for long-lasting operation of the device, which is critical not only for user convenience but also to keep costs as low as possible for the user.
Last Modified: 01/15/2022
Modified by: Amy J Beckley
Please report errors in award information by writing to: awardsearch@nsf.gov.
